J0180 Agalsidase beta injection
J-Codes
Also known as: agalsidase beta, Fabrazyme
Agalsidase beta injection, a recombinant enzyme replacement therapy for Fabry disease.
Clinical Context
Intravenous enzyme replacement therapy for Fabry disease (deficiency of alpha-galactosidase A). Reduces globotriaosylceramide accumulation in tissues, improving symptoms.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.